Christoph Grueneis, MBA, MSE
Christoph Grueneis combines deep pharmaceutical knowledge with strong strategic consulting skills. As a Senior Manager with a Global Consulting Company’s Life Sciences Strategy practice, partnered with worldwide Pharmaceutical and Biotechnology clients to develop and implement strategies across the Pharmaceutical value chain, from R&D to Supply Chain to Product Marketing. Christoph’s strong strategic skills are complemented by a practical approach and mindset developed through varied experiences in developing and delivering tactics ranging from promotional collateral to customer facing business processes for call centers and sales force automation.
Selected Engagements
- For a major biotech firm, led a team of strategy consultants to facilitate a client team through the process of developing, assessing and selecting a product distribution strategy. Key considerations for the project were having a full understanding of distribution model impacts in relation to changes in Medicare Part B, as well as, likely changes in wholesaler business models. The project delivered a selected distribution model, capability requirements and gaps, path forward and financial model. Through implementation of the selected model, our client expects to achieve overall cost savings driven by data collection savings, as well as, increased pricing flexibility, increased customer intimacy and improved track and trace capability.
- Delivered strategic market research to support the creation of a new Managed Markets Sales and Marketing group as the result of recent pharmaceutical mega-merger. Designed and conducted in-depth qualitative and quantitative research to uncover trends and shifting expectations on Managed Markets customers. The results of this research were instrumental in shaping the strategic direction and structure of the new organization.
- Led a strategic research effort to determine the feasibility of administering an Uninsured Patient Program through a drug card. As the work was performed for the client’s first drug to be available through retail Rx, key components of the work focused on; capabilities required, program costs, potential service partners and implications on patients and providers.
- Designed and facilitated a launch readiness workshop for a large non-US pharmaceutical company, in advance of the launch of their first product to be self-sold in the US. The session was designed to align the executive leadership, take a comprehensive view of needed activities, and create clear action plans for major functions across the company